Despite the advent of new science and technologies, drug developers will need to make radical changes in their operations if they are to remain competitive and innovative.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
In silico pharmacology: drug design and discovery’s gate to the future
In Silico Pharmacology Open Access 12 February 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Myers, S.D. et al. High performance drug discovery: an operating model for a new era. (Accenture Pharmaceuticals & Medical Products Practice, Chicago, IL; 2001)
Andersen Consulting. Reinventing drug discovery: the quest for innovation and productivity. (Andersen Consulting, New York, NY; 1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Myers, S., Baker, A. Drug discovery—an operating model for a new era. Nat Biotechnol 19, 727–730 (2001). https://doi.org/10.1038/90765
Published:
Issue Date:
DOI: https://doi.org/10.1038/90765
This article is cited by
-
User guide for the discovery of potential drugs via protein structure prediction and ligand docking simulation
Journal of Microbiology (2020)
-
Sulfonamide derivatives as Mycobacterium tuberculosis inhibitors: in silico approach
In Silico Pharmacology (2018)
-
Size does matter! Label-free detection of small molecule–protein interaction
Analytical and Bioanalytical Chemistry (2014)
-
In silico pharmacology: drug design and discovery’s gate to the future
In Silico Pharmacology (2013)
